Clinical Trial Update: The Effect of Bevacizumab on Corneal Neovascularization [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluated bevacizumab for corneal neovascularization and the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corneal Neovascularization

Drugs mentioned

• Avastin (bevacizumab)

Snippet

Sponsor: Instituto de Olhos de Goiania | Conditions: Corneal Neovascularization | Phase 4 | Status: COMPLETED